Drug Database
Back to search

United States· US:17856-0504_50b39d04-bda7-78bd-e063-6294a90a490d

Cyproheptadine Hydrochloride

A cyproheptadine product containing cyproheptadine hydrochloride, registered in United States by Atlantic Biological Corp.. The same ATC class is registered in 10 of our 19 countries.

ATC R06AX02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCyproheptadine HydrochlorideATCR06AX02REGISTER NO.US:17856-0504_50b39d0…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyproheptadine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyproheptadine is registered in 10 of 19 countries.

Countries holding a registration under ATC R06AX02 (cyproheptadine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search cyproheptadine products by name

Cyproheptadine · ATC R06AX02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CYPROHEPTADINE HYDROCHLORIDE
Manufacturer
Atlantic Biological Corp.
Country
United States (US)
ATC code
R06AX02
ATC class
Cyproheptadine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1785605041
    120 SYRINGE in 1 CASE (17856-0504-1) / 2.5 mL in 1 SYRINGE
  • ndc11
    17856-0504-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

327 interactions on record for cyproheptadine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyproheptadine against other medicinesHow interaction checks work

Cyproheptadine · interactions on record

327 records

  • 9 severe
  • 316 moderate
  • 2 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyproheptadine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyproheptadine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Czechia · Peritol
  • Germany · Peritol
  • Spain · Periactin
  • France · Periactine
  • Hungary · Peritol
  • Italy · Periactin
  • Poland · Peritol
  • Portugal · Viternum
  • Slovakia · Peritol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdc19c74-cc4c-4bf6-82e1-a4abaad06394
GET /v1/drugs/bdc19c74-cc4c-4bf6-82e1-a4abaad06394?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2",
  "substance": "CYPROHEPTADINE HYDROCHLORIDE",
  "productndc": "17856-0504",
  "dosage_form": "SYRUP",
  "dea_schedule": null,
  "strength_unit": "mg/5mL",
  "application_number": "ANDA040668",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about cyproheptadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console